549 related articles for article (PubMed ID: 27925791)
1. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
[TBL] [Abstract][Full Text] [Related]
2. Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation.
Pritchard J; Thakrar MV; Somayaji R; Surette MG; Rabin HR; Helmersen D; Lien D; Purighalla S; Waddell B; Parkins MD
J Cyst Fibros; 2016 May; 15(3):392-9. PubMed ID: 26657575
[TBL] [Abstract][Full Text] [Related]
3. Lung transplantation for non-cystic fibrosis bronchiectasis.
Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
[TBL] [Abstract][Full Text] [Related]
4. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
[TBL] [Abstract][Full Text] [Related]
5. Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.
Boutin S; Graeber SY; Weitnauer M; Panitz J; Stahl M; Clausznitzer D; Kaderali L; Einarsson G; Tunney MM; Elborn JS; Mall MA; Dalpke AH
PLoS One; 2015; 10(1):e0116029. PubMed ID: 25629612
[TBL] [Abstract][Full Text] [Related]
6. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis.
Walter S; Gudowius P; Bosshammer J; Römling U; Weissbrodt H; Schürmann W; von der Hardt H; Tümmler B
Thorax; 1997 Apr; 52(4):318-21. PubMed ID: 9196512
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
[TBL] [Abstract][Full Text] [Related]
9. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
[TBL] [Abstract][Full Text] [Related]
10. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.
Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
12. Effect of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis.
Srour N; Chaparro C; Vandemheen K; Singer LG; Keshavjee S; Aaron SD
J Heart Lung Transplant; 2015 Apr; 34(4):588-93. PubMed ID: 25455752
[TBL] [Abstract][Full Text] [Related]
13. The metabolic footprint of the airway bacterial community in cystic fibrosis.
Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
Vos R; Vanaudenaerde BM; Geudens N; Dupont LJ; Van Raemdonck DE; Verleden GM
Eur Respir J; 2008 May; 31(5):1037-45. PubMed ID: 18256072
[TBL] [Abstract][Full Text] [Related]
15. Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literature.
Carugati M; Piazza A; Peri AM; Cariani L; Brilli M; Girelli D; Di Carlo D; Gramegna A; Pappalettera M; Comandatore F; Grasselli G; Cantù AP; Arghittu M; Gori A; Bandi C; Blasi F; Bandera A;
BMC Infect Dis; 2020 Aug; 20(1):635. PubMed ID: 32847524
[TBL] [Abstract][Full Text] [Related]
16. Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections.
Williams D; Evans B; Haldenby S; Walshaw MJ; Brockhurst MA; Winstanley C; Paterson S
Am J Respir Crit Care Med; 2015 Apr; 191(7):775-85. PubMed ID: 25590983
[TBL] [Abstract][Full Text] [Related]
17. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
18. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
[TBL] [Abstract][Full Text] [Related]
19. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
